Which CRC Regimens Are More Likely to Harm Kidneys? Which CRC Regimens Are More Likely to Harm Kidneys?

After analyzing various treatments for metastatic colorectal cancer (CRC), researchers zeroed in on FOLFIRI  + bevacizumab. The study was published as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news